Formation Bio

Formation Bio is a tech-enabled drug development company. It addresses the clinical trials bottleneck in the drug development process by acquiring or in-licensing clinical-stage assets from pharmaceutical and biotechnology companies and conducting clinical trials more cost-effectively and faster. As of 2024, the company had supported hundreds of studies across the clinical trial timeline in roles ranging from recruitment vendor and tech partner to trial site manager and CRO. Its team and advisors have been involved in over 75 regulatory submissions as of May 2024, with over 45 drugs approved as of April 2025.